Gentex (GNTX) is positioned as a likely earnings beat candidate for Q3 2026 with a positive Earnings ESP of +0.66% and Zacks Rank #3, supported by a history of beating estimates. The company expects EPS of $0.51 (up 10.9% YoY) and revenues of $669.17 million (up 2.1% YoY). In contrast, peer Visteon (VC) faces challenges with a negative Earnings ESP of -4.05% and Zacks Rank #4, making an earnings beat unlikely despite modest revenue growth expectations.
VC
VISTEON CORPORATION · NASDAQ
Sign up free to see this.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about VC?
Latest news
News ›Visteon is expected to report Q3 2026 earnings of $2.35 per share (up 9.3% YoY) with revenues of $936.99 million (up 2.2% YoY) on October 22. However, the company carries a negative Earnings ESP of -4.05% and a Zacks Rank #4, making it unlikely to beat consensus estimates. Recent earnings history shows Visteon missed expectations in the last quarter by 14.35%, and has only beaten estimates twice in the last four quarters.
Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.